Diversified Trust Co Grows Stock Holdings in CME Group Inc. $CME

Key Points

• Diversified Trust Co increased its stake in CME Group by 147.4% during the second quarter, owning 2,590 shares valued at $714,000.
• CME Group recently received mixed ratings from analysts, with some lowering their target prices while others upgraded their ratings, resulting in an average "Hold" rating and a price target of $260.60.
• The company announced a quarterly dividend of $1.25 per share, with a yield of 1.9%, to be paid on September 25th to shareholders of record as of September 9th.

Diversified Trust Co lifted its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 147.4% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,590 shares of the financial services provider's stock after buying an additional 1,543 shares during the quarter. Diversified Trust Co's holdings in CME Group were worth $714,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of CME. Wayfinding Financial LLC bought a new stake in shares of CME Group in the 1st quarter worth about $25,000. Webster Bank N. A. grew its holdings in CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock valued at $25,000 after purchasing an additional 60 shares during the last quarter. Cornerstone Planning Group LLC boosted its position in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after buying an additional 55 shares during the period. Golden State Wealth Management LLC boosted its position in CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after buying an additional 98 shares during the period. Finally, Ransom Advisory Ltd purchased a new stake in CME Group in the 1st quarter valued at about $31,000. 87.75% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CME has been the subject of several research reports. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Citigroup upped their price target on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. UBS Group cut their price target on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research note on Monday, September 8th. Piper Sandler increased their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 15th. Finally, Barclays set a $298.00 price objective on shares of CME Group and gave the stock an "equal weight" rating in a research note on Thursday, July 24th. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, CME Group has an average rating of "Hold" and an average target price of $260.60.

Insider Activity at CME Group

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the business's stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the sale, the general counsel directly owned 7,851 shares of the company's stock, valued at approximately $2,056,962. The trade was a 4.76% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the business's stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock valued at $3,527,956 over the last 90 days. Insiders own 0.30% of the company's stock.

CME Group Price Performance

Shares of CME stock opened at $261.08 on Tuesday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The firm's 50-day moving average is $271.66 and its two-hundred day moving average is $270.86. CME Group Inc. has a 12 month low of $212.60 and a 12 month high of $290.79. The company has a market capitalization of $94.09 billion, a PE ratio of 25.27, a price-to-earnings-growth ratio of 4.73 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the firm earned $2.56 earnings per share. CME Group's quarterly revenue was up 10.4% compared to the same quarter last year. Analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group's payout ratio is 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.